Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma

A Zaidi, S Dresman, B Charoltte, S Rule, LMR McCallum

Research output: Contribution to journalArticlepeer-review

6 Downloads (Pure)

Abstract

Mantle cell lymphoma (MCL) is a comparatively rare non-Hodgkin’s lymphoma characterised by overexpression of cyclin D1.Many patients present with or progress to advanced stage disease within 3 years. MCL is considered an incurable disease withmedian survival between 3 and 4 years. We have investigated the role(s) of CCN1 (CYR61) and cell cycle regulators inprogressive MCL. We have used the human MCL cell lines REC1 < G519 < JVM2 as a model for disease aggression. Themagnitude of CCN1 expression in human MCL cells is REC1 > G519 > JVM2 cells by RQ-PCR, depicting a decrease in CCN1expression with disease progression. Investigation of CCN1 isoform expression by western blotting showed that whilst expres-sion of full-length CCN1 was barely altered in the cell lines, expression of truncated forms (18–20 and 28–30 kDa) decreasedwith disease progression. We have then demonstrated that cyclin D1 and cyclin dependent kinase inhibitors (p21CIP1and p27KIP1)are also involved in disease progression. Cyclin D1 was highly expressed in REC1 cells (OD: 1.0), reduced to one fifth in G519cells (OD: 0.2) and not detected by western blotting in JVM2 cells. p27KIP1followed a similar profile of expression as cyclin D1.Conversely, p21CIP1was absent in the REC1 cells and showed increasing expression in G519 and JVM2 cells. Subcellularlocalization detected p21CIP1/p27KIP1primarily within the cytoplasm and absent from the nucleus, consistent with altered roles in treatment resistance. Dysregulation of the CCN1 truncated forms are associated with MCL progression. In conjunction withreduced expression of cyclin D1 and increased expression of p21, this molecular signature may depict aggressive disease andtreatment resistance.
Original languageEnglish
Number of pages0
JournalJournal of Cell Communication and Signaling
Volume0
Issue number0
Early online date21 Nov 2018
DOIs
Publication statusPublished - 21 Nov 2018

Fingerprint

Dive into the research topics of 'Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma'. Together they form a unique fingerprint.

Cite this